Literature DB >> 25630029

Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease.

Giuseppe Cataldo1, Sugandha Rajput, Kalpna Gupta, Donald A Simone.   

Abstract

Chronic pain is a major characteristic feature of sickle cell disease (SCD). The refractory nature of pain and the development of chronic pain syndromes in many patients with SCD suggest that central neural mechanisms contribute to pain in this disease. We used HbSS-BERK sickle mice, which show chronic features of pain similar to those observed in SCD, and determined whether sensitization of nociceptive neurons in the spinal cord contributes to pain and hyperalgesia in SCD. Electrophysiological recordings of action potential activity were obtained from single identified dorsal horn neurons of the spinal cord in anesthetized mice. Compared with control HbAA-BERK mice, nociceptive dorsal horn neurons in sickle mice exhibited enhanced excitability as evidenced by enlarged receptive fields, increased rate of spontaneous activity, lower mechanical thresholds, enhanced responses to mechanical stimuli, and prolonged afterdischarges following mechanical stimulation. These changes were accompanied by increased phosphorylation of mitogen-activated protein kinases (MAPKs) in the spinal cord that are known to contribute to neuronal hyperexcitability, including c-Jun N-terminal kinase (JNK), p44/p42 extracellular signaling-regulated kinase (ERK), and p38. These findings demonstrate that central sensitization contributes to pain in SCD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25630029      PMCID: PMC4366346          DOI: 10.1097/j.pain.0000000000000104

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  51 in total

Review 1.  Intracellular signaling in primary sensory neurons and persistent pain.

Authors:  Jen-Kun Cheng; Ru-Rong Ji
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 3.996

Review 2.  Spinal presynaptic inhibition in pain control.

Authors:  D Guo; J Hu
Journal:  Neuroscience       Date:  2014-09-22       Impact factor: 3.590

3.  Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

Authors:  Cheryl A Hillery; Patrick C Kerstein; Daniel Vilceanu; Marie E Barabas; Dawn Retherford; Amanda M Brandow; Nancy J Wandersee; Cheryl L Stucky
Journal:  Blood       Date:  2011-06-27       Impact factor: 22.113

Review 4.  Emerging role of Toll-like receptors in the control of pain and itch.

Authors:  Tong Liu; Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

Review 5.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

6.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

Review 7.  MAP kinase and pain.

Authors:  Ru-Rong Ji; Robert W Gereau; Marzia Malcangio; Gary R Strichartz
Journal:  Brain Res Rev       Date:  2008-12-25

Review 8.  MAPK activation in nociceptive neurons and pain hypersensitivity.

Authors:  Koichi Obata; Koichi Noguchi
Journal:  Life Sci       Date:  2004-04-09       Impact factor: 5.037

9.  Cold hypersensitivity increases with age in mice with sickle cell disease.

Authors:  Katherine J Zappia; Sheldon R Garrison; Cheryl A Hillery; Cheryl L Stucky
Journal:  Pain       Date:  2014-06-03       Impact factor: 6.961

Review 10.  p38 MAPK, microglial signaling, and neuropathic pain.

Authors:  Ru-Rong Ji; Marc R Suter
Journal:  Mol Pain       Date:  2007-11-01       Impact factor: 3.395

View more
  47 in total

1.  Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice.

Authors:  Yessenia Valverde; Barbara Benson; Mihir Gupta; Kalpna Gupta
Journal:  Haematologica       Date:  2015-11-06       Impact factor: 9.941

2.  Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice.

Authors:  Derek Vang; Jinny A Paul; Julia Nguyen; Huy Tran; Lucile Vincent; Dennis Yasuda; Nurulain T Zaveri; Kalpna Gupta
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

Review 3.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

Review 4.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 5.  New insights into sickle cell disease: mechanisms and investigational therapies.

Authors:  Gregory J Kato
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

6.  Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Authors:  Maha Khaleel; Mammen Puliyel; Payal Shah; John Sunwoo; Roberta M Kato; Patjanaporn Chalacheva; Wanwara Thuptimdang; Jon Detterich; John C Wood; Jennie Tsao; Lonnie Zeltzer; Richard Sposto; Michael C K Khoo; Thomas D Coates
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

7.  Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease.

Authors:  Deepika S Darbari; Johnson P Hampson; Eric Ichesco; Nadja Kadom; Gilbert Vezina; Iordanis Evangelou; Daniel J Clauw; James G Taylor Vi; Richard E Harris
Journal:  J Pain       Date:  2015-08-18       Impact factor: 5.820

8.  Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.

Authors:  C Patrick Carroll; Sophie Lanzkron; Carlton Haywood; Kasey Kiley; Megan Pejsa; Gyasi Moscou-Jackson; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

9.  Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum.

Authors:  Li Wang; Luis E F Almeida; Celia M de Souza Batista; Alfia Khaibullina; Nuo Xu; Sarah Albani; Kira A Guth; Ji Sung Seo; Martha Quezado; Zenaide M N Quezado
Journal:  Neurobiol Dis       Date:  2015-10-14       Impact factor: 5.996

10.  Changes in Pain and Psychosocial Functioning and Transition to Chronic Pain in Pediatric Sickle Cell Disease: A Cohort Follow-up Study.

Authors:  Soumitri Sil; Lindsey L Cohen; Nitya Bakshi; Amanda Watt; Morgan Hathaway; Farida Abudulai; Carlton Dampier
Journal:  Clin J Pain       Date:  2020-06       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.